Table 3.
Lupuzor | |||
---|---|---|---|
Group 1 (200 μg every 4 weeks) | Group 2 (200 μg every 2 weeks) | Group 3 (placebo) | |
Week 12 | n=49 | n=51 | n=47 |
Responders, n (%) | 26 (53.1) | 23 (45.1) | 17 (36.2) |
p=0.048 | p=0.18 | – | |
Week 24 | n=49 | n=51 | n=49 |
Responders, n (%) | 29 (59.2) | 30 (58.8) | 26 (53.1) |
p=0.27 | p=0.28 | – |
p Values compare Lupuzor with placebo. Drop-outs are considered as non-responders.
ITT, intention-to-treat; SRI, SLE Responder Index.